These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25054994)

  • 1. Overlapping MRI findings in progressive supranuclear palsy - corticobasal syndrome.
    Prezzi ED; Vasconcellos LF; Marussi VH
    Arq Neuropsiquiatr; 2014 Jul; 72(7):569-70. PubMed ID: 25054994
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
    Hirano S; Shinotoh H; Shimada H; Aotsuka A; Tanaka N; Ota T; Sato K; Ito H; Kuwabara S; Fukushi K; Irie T; Suhara T
    Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
    Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
    Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key emerging issues in progressive supranuclear palsy and corticobasal degeneration.
    Josephs KA
    J Neurol; 2015 Mar; 262(3):783-8. PubMed ID: 25701010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson's disease.
    Miyata M; Kakeda S; Toyoshima Y; Ide S; Okada K; Adachi H; Wang Y; Korogi Y
    Neuroradiology; 2019 Nov; 61(11):1251-1259. PubMed ID: 31267152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.
    Boeve BF; Lang AE; Litvan I
    Ann Neurol; 2003; 54 Suppl 5():S15-9. PubMed ID: 12833363
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-occurrence of radiological features of progressive supranuclear palsy and corticobasal degeneration.
    Divatia R; Khan F; Kishore A
    Neurol India; 2007; 55(1):75-7. PubMed ID: 17272907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy.
    Ikeda K; Akiyama H; Haga C; Kondo H; Arima K; Oda T
    Neurosci Lett; 1994 Jun; 174(2):157-9. PubMed ID: 7526285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticobasal degeneration presenting with progressive spasticity.
    Hasselblatt M; Föllinger S; Steinbach P; Schwan A; Paulus W
    Neurology; 2007 Mar; 68(10):791-2. PubMed ID: 17339593
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-synuclein studies are negative in postencephalic parkinsonism of von Economo.
    Josephs KA; Parisi JE; Dickson DW
    Neurology; 2002 Aug; 59(4):645-6. PubMed ID: 12196673
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.
    Okuda B; Tachibana H; Kawabata K; Takeda M; Sugita M
    Alzheimer Dis Assoc Disord; 2000; 14(1):46-52. PubMed ID: 10718204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropathology of corticobasal degeneration].
    Wakabayashi K; Takahashi H
    No To Shinkei; 1996 Jun; 48(6):521-32. PubMed ID: 8703555
    [No Abstract]   [Full Text] [Related]  

  • 15. Diffuse lewy body disease presenting as corticobasal syndrome and progressive supranuclear palsy syndrome.
    Haug A; Boyer P; Kluger B
    Mov Disord; 2013 Jul; 28(8):1153-5. PubMed ID: 23400932
    [No Abstract]   [Full Text] [Related]  

  • 16. IgLON5 autoimmunity tested negative in patients with progressive supranuclear palsy and corticobasal syndrome.
    Mangesius S; Sprenger F; Höftberger R; Seppi K; Reindl M; Poewe W
    Parkinsonism Relat Disord; 2017 May; 38():102-103. PubMed ID: 28285943
    [No Abstract]   [Full Text] [Related]  

  • 17. Morning glory sign is not prevalent in progressive supranuclear palsy.
    Mori H; Aoki S; Ohtomo K
    Magn Reson Med Sci; 2004; 3(4):215; author reply 216-7. PubMed ID: 16093641
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Yagishita S; Takamatsu J
    Neuroreport; 2001 Apr; 12(5):935-8. PubMed ID: 11303763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticobasal degeneration: widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy.
    Takahashi T; Amano N; Hanihara T; Nagatomo H; Yagishita S; Itoh Y; Yamaoka K; Toda H; Tanabe T
    J Neurol Sci; 1996 Jun; 138(1-2):66-77. PubMed ID: 8791241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corticobasal degeneration].
    Takahashi T
    Nihon Rinsho; 2004 Jan; 62 Suppl():113-7. PubMed ID: 15011331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.